Sunshine Biopharma, Inc. (SBFM)

NASDAQ: SBFM · IEX Real-Time Price · USD

0.320

-0.082 (-20.48%)

At close: Jul 2, 2024, 4:00 PM

0.333

+0.013 (4.00%)

After-hours: Jul 2, 2024, 7:54 PM EDT

Sunshine Biopharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2007
Net Income	-4.51	-26.74	-12.44	-2.78	-1.66	Upgrade
Depreciation & Amortization	0.15	0.03	0.01	0.01	0.01	Upgrade
Share-Based Compensation	0	0	0.92	0.05	0.26	Upgrade
Other Operating Activities	-4.42	21.47	9.68	2.06	0.89	Upgrade
Operating Cash Flow	-8.78	-5.25	-1.83	-0.66	-0.5	Upgrade
Capital Expenditures	0.05	-0.16	0	-0	-0	Upgrade
Acquisitions	0	-14.35	0	0	-0.01	Upgrade
Other Investing Activities	-0.71	-0.11	-	-	-	Upgrade
Investing Cash Flow	-0.66	-14.62	0	-0	-0.02	Upgrade
Share Issuance / Repurchase	3.55	30.27	0	0	0	Upgrade
Debt Issued / Paid	-0.13	-1.93	2.84	1.57	0.44	Upgrade
Other Financing Activities	0	11.13	0.06	0.04	-	Upgrade
Financing Cash Flow	3.43	39.47	2.9	1.61	0.44	Upgrade
Exchange Rate Effect	0.47	0.18	-0.02	-0	-0.01	Upgrade
Net Cash Flow	-6.01	19.6	1.08	0.95	-0.07	Upgrade
Free Cash Flow	-8.73	-5.41	-1.83	-0.66	-0.5	Upgrade
Free Cash Flow Margin	-36.22%	-124.47%	-800.75%	-922.13%	-2351.49%	Upgrade
Free Cash Flow Per Share	-35.86	-35.63	-70.03	-64.53	-908.56	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).